Updated: Sep 30, 2022
Peer Review Article | Open Access | Published 30th September 2022
Identification of Bacterial Isolates Recovered from the Surface of Cleanroom Operators’ Garments following Wear
Dr Laurie M. Smith, Dr Christina Lowes, Dr Noëlle H. O’ Driscoll, Prof Andrew J. Lamb | EJPPS | 273 (2022) | https://doi.org/10.37521/ejpps.27301| Click to download pdf
Back to Journals | Abstract | Introduction | Conclusion | References | Author Information
This investigation was undertaken in the School of Pharmacy and Life Sciences at Robert Gordon University, Sir Ian Wood Building, Garthdee, Aberdeen, UK.
Contamination of sterile pharmaceutical products can have serious consequences, in worst case scenario resulting in patient death. Cleanroom operators are the primary source of microbial contamination, where the surface of their specialist sterile clothing garments is subject to such contamination during wear. In turn these garments become a transmission vector for microorganisms within the cleanroom environment. Insight into identification of predominant bacterial isolates from garment surfaces would help to establish their original source and probable contamination route. This should assist possible intervention strategies to mitigate against this contamination.
The research aimed to determine identity of representative bacterial isolates recovered from the surface of cleanroom operators’ garments following wear within a cleanroom.
Following isolation and purification of bacterial isolates, 16S rRNA gene sequencing was used to establish species identity for isolates recovered from the surface of male and female operators’ garments following wear within the cleanroom environment.
Of the 47 isolates recovered from the surface of garments, 16S rRNA gene sequencing successfully identified 94 % to genus level and 77 % to species level. Most were confirmed as Gram - positive bacteria; predominantly species of Staphylococcus, Micrococcus and Bacillus. The isolates recovered from the surface of female operatives’ garments were more diverse than those retrieved from male counterparts.
Most isolates recovered from garments were found to be skin commensals, with nearly 70% attributed to the operators within the environment. The remainder were credited to contamination of garments with species of environmental origin. Whilst most bacteria identified present minimal threat to healthy individuals, certain of these are opportunistic pathogens, presenting a hazard for immunocompromised and/or those with underlying health conditions.
Microbial contamination of pharmaceutical cleanrooms and subsequently products can have serious consequences including product recalls (1,2), shutdowns and increased expenditure (3), infection (4,5) and in worst case scenario death of product recipients (6–8). An effective environmental microbial monitoring programme is fundamental for ensuring contamination control (9). These programmes aid identification of habitual microflora, establishing predominant isolates and ascertaining probable source and routes of transfer into the cleanroom (10,11).
Findings from these monitoring programmes evidence a correlation between bacteria resident on human skin and those present within the cleanroom environment (12–17); attributing operators as the principal contamination source (18–23). Eighty percent of operator contamination is in the form of dead skin squames (24). A small percentage of these harbour skin associated microorganisms, so called microbe carrying particles (MCPs) (25). Failures of cleanroom garments to retain such squames and MCPs has been extensively reported (18–21,23,26,27). These studies confirmed properly gowned operatives disperse approximately 17,000 particles (21), including 180 MCPs per minute into the cleanroom environment (20). The polyester fibres of reusable garments were found to offer a substratum for microbial adherence, survival and growth (28–30) and that garment surfaces are subject to bacterial contamination following wear (31,32). In turn, garments become a vector for microbial dissemination within a cleanroom either via indirect airborne transmission (33) or direct surface transfer (34,35).
Several studies have investigated microbial populations within cleanroom environments (12–17,36–41), with over 70% of isolates originating from the human microbiome (17). Gram-positive bacteria are commonly observed in pharmaceutical cleanrooms, predominantly species of Staphylococcus and Micrococcus (12,15–17,39,40). Indeed, a 9-year review of cleanroom isolates investigating the types, trends, and patterns of cleanroom microflora, reports over 50% of isolates as such species (12). In addition, environmental Bacillus species account for 10-13% of isolates, whilst a much lower percentage of Gram-negative bacteria are present (12). However, few studies assess bacterial populations on operators and their garments (12,31,42), where just two have attempted to undertake identification to species level (31,42), one focused solely on Staphylococcus species using the API Staph identification system (42).
Microbial identification tests typically classify microorganisms to their genus or species level (43). Traditional phenotypic methods involve identification based on observable characteristics, derived from several biochemical tests. However, such techniques are labour intense and subject to limitations including reliance on expression of metabolic activities, interpretation of subjective results, reproducibility, and observation of similar phenotypic characteristics between isolates. Consequently, isolates can be misidentified (44) or remain unidentified (45). In contrast, genotypic sequence-based identification is considered more reliable with 16S rRNA gene sequencing reported to identify over 80 % of isolates to the species level (46). Despite the emergence of genotypic techniques, phenotypic methods are still commonly employed in cleanroom isolate identification (12).
Identification of isolates on cleanroom garments and determination of their origin is vital in assessing operator associated environmental and product risks and foreseeing incidences of contamination. Therefore, the aim of this study was to use 16S rRNA gene sequencing to seek identification and origin of bacterial isolates recovered from the surface of cleanroom operators’ garments following wear.
2.1 Bacterial Recovery
Bacterial isolates were recovered during our study examining influence of gender on the surface contamination of clean room operators’ garments following wear (32). During this investigation the surface of clean room operators’ garments were tested within the exit area of the changing area, prior to garment removal and immediately following their period of working in the cleanroom environment. The method used to recover bacteria from garments involved a direct agar contact method, where the surface of a nutrient agar contact plate was depressed against the surface of the garments at specific sites for a period of 5 seconds at constant pressure (Figure 1). Following colony enumeration from the incubated contacts plates for the study reported earlier (32), a total of 47 representative colonies were selected for this study based upon morphological characteristics. Of the total, 36 isolates were obtained from contact plates examining female operatives’ garments with 11 isolates taken from garments worn by their male counterparts.
Figure 1: Garment sites tested: 1- chest, 2 - umbilicus, 3 - posterior cervicis, 4 - lumbus, 5/6 - left and right carpus and 7 - oral cavity.
2.2 Bacterial Purification and DNA Extraction
Colonies of isolates were picked, streaked and then re-streaked to purity on nutrient agar plates incubated at 37 ℃, then stored at 4 ℃ prior to DNA extraction. To permit DNA extraction 1 mL of overnight culture in nutrient broth (prepared from a well isolated colony of the isolate) was centrifuged in a sterile 1.5 mL micro centrifuge tube for 5 minutes at 13,500 rpm. After supernatant was removed the pellet was re - suspended in 100 µL of 10 mg/mL lysozyme solution in 0.1 M TE Buffer for 45 minutes at 37 ℃. Following this, 1 µL of 20 mg/mL Proteinase K (Sigma Aldrich, Dorset, UK) and 1 µL of 10 % SDS solution were added and incubated for a further 30 minutes, before 100 µL of 30 % (w/v) BT Chelex® 100 resin (BioRad Laboratories, CA, USA) was added. After addition of resin the tube was vortex mixed. To optimise DNA yield the tube was heated to 56 ℃ for 30 minutes in a heating block then boiled for 10 minutes in a water bath to further promote bacterial cell lysis. The tube was centrifuged for 5 minutes at 13,500 rpm and ~ 200 µL of supernatant transferred into a fresh sterile 1.5 mL micro centrifuge tube. Gel electrophoresis using 10 µL of supernatant on a 1.5 % (w/v) agarose gel was performed to establish successful DNA extraction. The remainder was frozen at -20 ℃ for future analysis.
2.3. Polymerase Chain Reaction (PCR) Amplification of Extracted Bacterial DNA
16S rRNA forward and reverse primers (synthesised by Sigma Aldrich, Dorset, UK) were used to amplify the 320 bp hypervariable region at the 5‘- end of the 16S rRNA gene in each of the isolates selected for study. The sequence and melting temperatures of the primers to obtain the anticipated PCR amplicon size of 320 bp are shown in Table 1.
Table 1: 16S rRNA forward and reverse primer sequence and melting temperatures.
Primers were stored at -20 ℃ and thawed at room temperature prior to dilution with sterile Milli–Q water down to a working concentration of 10 mM. For each extracted DNA sample 50 µL of PCR master mix was prepared by addition of 10 µL of 5 x PCR buffer, 3 µL of 25 mM MgCl2, 1 µL of 10mM dNTPs (all Bioline Ltd, London, UK), 1 µL of each forward and reverse primer and 35 µL of Milli–Q water in a sterile 1.5 mL micro centrifuge tube. Thereafter, the PCR reaction contained 50 µL of PCR master mix, 5 µL of extracted bacterial DNA and 1 µL Taq polymerase (5 units / µL) (Bioline Ltd, London, UK).
PCR was undertaken in a Jencons – PLS Techne TC – 312 thermo cycler (Jencons Scientific Ltd, Bedfordshire, UK). Initially, samples were denatured at 94 ℃ for five minutes before undergoing 30 thermal cycles of denaturing at 94 ℃ for 1 minute, annealing at 63 ℃ for 1 minute and elongation at 72 ℃ for 2 minutes. A final elongation stage of 10 minutes at 72 ℃ was undertaken. To determine successful amplification and DNA concentration within each sample 10 µL from the reaction was subjected to gel electrophoresis on a 1.5 % (w/v) agarose gel.
2.4. Purification of Amplified Bacterial DNA Samples
Amplified DNA samples obtained by PCR were purified using the Wizard® SV Gel and PCR Clean Up System (Promega, Southampton, UK). In a sterile 1.5 mL micro centrifuge tube 40 µL of PCR product was added to 40 µL of membrane binding solution. Following mixing, an SV mini column was inserted into a collection tube and the 80 µL of PCR product/membrane binding solution transferred onto the column. This was incubated for 1 minute at room temperature, before being centrifuged at 16,000 x g for a further 1 minute. The column was removed from the collection tube and the flow-through discarded. The column was re-inserted into the collection tube and washed using 700 µL of membrane wash solution and centrifuged at 16,000 x g for 1 minute. The flow through was once again discarded and the column re-inserted into the collection tube. This washing process was repeated with 500 µL of membrane binding solution and centrifuged for 5 minutes at 16,000 x g. The collection tube was again emptied and the column re-centrifuged at 16,000 x g to allow evaporation of any residual ethanol. To elute the PCR product from the mini column this was placed into a sterile 1.5 mL micro centrifuge tube and 50 µL of nuclease free water added. This was incubated at room temperature for 1 minute and centrifuged at 16,000 x g for a further 1 minute. Purified DNA products were all stored at -20 ℃ for future analysis.
2.5. Preparation of PCR Samples for Sequencing
After determining the concentration of DNA within each sample from the agarose gel electrophoresis detailed in section 2.3 the concentration of each sample was adjusted to give between 10 - 20 ng in 30 µL of Milli-Q water (0.33 - 0.67 ng / µl). DNA sequencing was performed by the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee (MRC PPU Unit, School of Life Sciences, University of Dundee, Scotland - https://www.dundee.ac.uk/facilities/mrc-ppu-dna-sequencing-and-services).
2.6. Basic Local Alignment Selection Tool (BLAST) Analysis of Bacterial DNA Sequences
DNA sequences were converted to the FASTA (text – based) format and entered into BLAST (http://blast.ncbi.nlm.nih.gov/) for comparison to sequences stored in the 16S rRNA sequence database. Identification to species level was considered successful when a similarity of > 97 % was achieved to a sequence in the database. For those sequences which did not meet these criteria they were only identified to the genus level where a > 95 % similarity was observed (47).
To permit genotypic identification of the 47 bacterial isolates recovered from the surface of cleanroom operators’ garments following working in the cleanroom environment, 16S rRNA gene sequencing was undertaken. Of these, 44 isolates were identified to at least the genus level (> 95% similarity to a sequence in the BLAST database). Two further isolates could not be identified to the genus level as both achieved only 85% similarity within the BLAST database. Furthermore, somewhat surprisingly, one of the isolates had a sequence for which no significant similarities were found within the BLAST database.
3.1 Characteristics of Bacterial Isolates Identified to Genus Level
Of the 44 isolates identified via BLAST, 28 were confirmed as Gram - positive cocci, 14 as Gram - positive rods, and 1 being a Gram - negative coccus. The last of this batch of isolates was identified as a species of Brachybacterium, where cell shape varies and exhibits an unusual rod-coccus cycle of growth (48). The common habitat of these bacteria, as well as their predicted source for contamination of the cleanroom garments, are reported in Table 2. As shown, most bacterial isolates were identified as species of Staphylococcus, Micrococcus and Bacillus. Smaller numbers of Microbacterium were found along with individual isolates of Brachybacterium, Dermacoccus, Kocuria, Paenibacillus or Psychrobacter species. Based on genera, isolates were identified as either common members of human skin microbiome or the outdoor environment. Indeed, 28 isolates (64 %) were therefore determined to have originated from the wearer of the garments, whilst 16 isolates (36 %) could be attributed to environmental contamination.
Table 2: Characterisation of Bacterial Isolates Recovered from Worn Cleanroom Garments.
3.2. Effect of Gender on Microbial Diversity of Cleanroom Garments
The effect of gender on the diversity of isolates on the surface of cleanroom operators’ garments following wear was reviewed. The relative proportions of isolates by genera and with respect to gender is illustrated in Figure 2. This represents 33 isolates recovered from the surface of female operatives’ garments and 11 isolates recovered from the surface of garments worn by their male counterparts.
Figure 2: Proportions of bacterial isolates recovered from the surface of male and female cleanroom operators’ garments.
As shown in Figure 2, staphylococci were most commonly recovered from the surface of garments worn by both male and female operators, whilst similar proportions of Bacillus spp. were noted in each case. A greater proportion of Micrococcus spp. were identified from garments worn by female operators compared to those worn by their male counterparts. Microbacterium spp. were recovered from male operatives’ garments whereas the same genus was not retrieved from garments worn by their female counterparts. A greater diversity of bacteria was identified from the surface of garments worn by female operators including species of Brachybacterium, Dermacoccus, Kocuria, Paenibacillus and Psychrobacter. Of course, it must be acknowledged that the smaller original number of isolates examined from male operators’ garments make this comparison less reliable.
3.3. Identification of Bacterial Isolates to Species Levels.
Of the 44 isolates identified to the genus level, 36 of these proved possible to be identified to species level (> 97% similarity to a sequence in the BLAST database). Their site of garment recovery with respect to gender are reported in Table 3.
Table 3: Species level identification of bacterial isolates recovered from the surface of female or male cleanroom operators’ garments.
The most abundant species recovered from the surface of garments worn by female operatives was Micrococcus luteus. Several species of Staphylococcus were also recovered from garments worn by both genders with S. succinus and S. cohnii most commonly found. Environmental Bacillus species, including B. anthracis, were retrieved from garments worn by both genders.
Bacteria recovered from the surface of female operators’ garments were slightly more diverse than those from males, with single isolates of Brachybacterium conglomeratum, Kocuria gwangalliensis and Psychrobacter pulmonis all identified. However, two isolates recovered from garments worn by male operatives were identified as Microbacterium martipicum, a species not recovered from females. Overall, there did not appear to be a correlation between garment site and the bacterial species recovered, with a diverse population of bacteria across garment sites observed.
The results confirm that sterile barrier clothing worn by operators within a cleanroom facility to guard against product contamination, becomes rapidly contaminated with bacteria and thereby presents a potential contamination risk. Whilst most bacterial organisms identified from the garments present minimal threat to healthy individuals, others identified are known opportunist pathogens. The latter harbour ability to cause infection and disease in immunocompromised persons or those with underlying health conditions.
Of those bacterial isolates identified in this study, other than one, all were found to be Gram - positive organisms; primarily cocci. This might have been anticipated due to the abundance of Gram – positive bacteria on human skin (58), their previously reported prevalence within the cleanroom environment (12,15–17,39), and their incidence on the surface of cleanroom operators’ garments (12,31). Of note, species of Bacillus identified in this study produce spores which survive extreme habitat fluctuations for extended periods of time, also withstanding desiccation and disinfection (59). These present increased risk to the cleanroom, due to potential to remain inactive for a prolonged period before sporulating back to vegetative growth under appropriate conditions.
Most isolates were identified as species of Gram - positive cocci, either Staphylococcus or Micrococcus. The presence of these particular bacteria confirms contamination of sterile barrier clothing by the operators during gowning or working within the cleanroom. Findings from this study indicate approximately two thirds of isolates recovered from the garments can be attributed to this source. As noted by Grangé et al. (2010) (31) and an earlier study reported from our laboratory (32) bacteria will contaminate the outer surface of operators’ garments whilst they work. The remaining one third of isolates identified are non - human in origin where contamination probably arose from an environmental source. Several isolates which derive from soil were identified, their presence attributed to operator transfer and / or materials being brought into the cleanroom and subsequently transferred onto the garment via surface contact. In their study of cleanroom contamination routes Moissi - Enichinger et al. (2015) (60) found the operator changing area to be the primary location for bacterial transmission into the cleanroom environment, with 68 % of cleanroom isolates originating from this area (60). This relates to movement of personnel and transfer of materials from contaminated unclassified areas, coupled to elevated level of activity within this area (including garment donning process). Increased movement promotes particles including MCPs to be disseminated from operators. Complete mitigation of such activities is both impractical and unavoidable, where we previously reported contamination of cleanroom garments at the point of their donning, critically being prior to actual cleanroom entry (61).
The single most abundant isolate observed was the skin commensal Micrococcus luteus, an organism responsible for 25 % of all cleanroom contamination events (62). Although an opportunist pathogen causing nosocomial infections such as meningitis (63), septic shock (64), endocarditis (65) and brain abscess (66), diseases are rare and limited to those with lowered immunity. A range of Staphylococcus species isolates including S. succinus, S. cohnii, S. equorum, S. capitis, S. hominis and S. saprophyticus were also identified. Whilst the majority of these are skin commensal and attributed to the wearer / operators within the environment, S. equorum and S. succinus are not reported to originate from humans (67,68) and not in keeping with expected operator and / or environmental transmission sources. Were the bar for species identification increased from 97% sequence identity of 16S rRNA sequence, it might be the case these could have been found to be different species that are human in origin.
Environmental Bacillus were also recovered, with species of B. anthracis, B. safensis and B. pumilus identified, the former the cause of anthrax (69). These bacteria are common soil inhabitants (70) and as such the route onto the clothing garment is thought to be through operator transfer from the external environment, probably via footwear. These species are commonly found in pharmaceutical cleanrooms and are regarded as problematic (71). Whilst the pathogenicity of B. safensis is not clearly evidenced (72), although rare, B. pumilus has been reported to cause infection (73–77). However, it is worth noting that using 16S rRNA gene sequencing some Bacillus species exhibit more than 99 % sequence similarity (78) and in this study Bacillus isolates may not be identified accurately beyond genus level.
In this study isolates exhibiting a > 97% similarity to a sequence within the BLAST database were considered positively identified to species level, as previously recommended by Schloss and Handelsman (47). However, it is also reported that over 97 % the differentiation between species is not entirely clear, as noted previously with some Bacillus species sharing > 99.5% sequence similarity (71). As such, Stackebrandt and Ebers (79) recommend a 98.7 – 99 % gene sequence similarity threshold to successfully identify isolates to the species level (79). Critically, although this increased threshold would reduce species identification efficiency in this study to just below 50 %, the 97% sequence similarity requirement selected permits bacterial genus identification with complete certainty. Indeed, if the primary purpose of identification is determination of isolate source, speciation of Bacillus spp. would not add any more value. Furthermore, misidentification of potentially pathogenic species such as B. anthracis may lead to unnecessary concern. In such cases phenotypic identification of isolates to the genus level may prove just as helpful while being less onerous and less costly. However, at the onset of this investigation the genus of the recovered isolates were unknown and 16S rRNA gene sequencing gave insight into the genus, as well as provisional speciation. Undeniably, the authors recognise that despite the advantages of 16S rRNA gene sequencing over phenotypic approaches, no bacterial identification method other than complete genome sequencing can be 100% accurate (80).
Bacteria recovered from the surface of female operators’ garments were more diverse than those retrieved from their male co-workers’. Gender has been previously shown to affect diversity of the skin microbiome, with greater variety observed on female skin (81,82) in keeping with the findings from the present study. The reason behind gender-linked skin microbiome differences is not well documented but thought to be attributed in part to physiological skin differences (82). The skin microbiome has also been shown to vary with host and environmental factors (58) and whilst wearing cleanroom garments body temperature and microclimate relative humidity have been shown to vary between genders (83,84). As well as an increased variety of bacterial genera identified, some of those recovered were unique to female operatives’ garments, including environmental Brachybacterium and Psychrobacter, and skin commensal Kocuria. Whilst first reported in 1995 (85) Brachybacterium conglomeratum is an understudied organism with the limited literature restricting explanation for its presence on the garment. In contrast, Microbacterium martipicum was uniquely recovered from male workers clothing. Aside from the identification of this species in soil (86), there is little further information about this organism within the literature. However, it should be noted that as with Bacillus, species of Microbacterium have been shown to exhibit very similar 16S rRNA gene sequencing profiles and may be difficult to identify accurately at species level (87). In respect to the sample site from which the bacterial isolates were recovered there was no relationship identified between organism identity and the location where the sample was taken from the garment. However, due to the large number of sites relative to the number of isolates, it would be unwise to suggest that no such correlation could exist.
In addition to the matter of similarity threshold applied for determination of bacterial species identity, other limitations for this study existed, primarily the inability to undertake a completely quantitative study for identification of all bacterial isolates. To achieve a semi-quantitative outcome, isolates selected were based upon colony morphology which sought to achieve proportionate representation. The study did not consider the exact grade of cleanroom in which the garments were worn beyond being isolates from operatives working within the facility, or the environmental parameters therein. Furthermore, although the operator numbers were always within standard operating procedure for the facility, the exact numbers of people within the cleanroom were not recorded. Previously Sandle (2011) reported that such factors will influence microbial diversity within the cleanroom environment (12). It is acknowledged this would have impacted upon the range and types of bacteria recovered from the surface of cleanroom operators’ garments. Another was the variable length of time for which the garments were worn, being within periods of no less than 30 minutes to no more than 90 minutes, where bacterial number on cleanroom garments is known to increase with time (31,32). Collectively these all place limitations on the study findings and each would be worthy of separate further investigation with respect to the identity of bacterial contaminants recovered from cleanroom operators’ garments.
Using 16S rRNA gene sequence comparisons this successfully identified 44 of 47 bacterial isolates recovered from the surface of cleanroom operators’ garments to genus level and 36 down to species level. Virtually all isolates were identified as Gram - positive species, most being Staphylococcus, Micrococcus and Bacillus. Nearly 70 % of identified isolates were attributed to the operator contamination within the cleanroom facility and the remainder resulting from environmental source of contamination. The specialist garments worn by cleanroom operators eventually become contaminated with bacteria and thereafter represent a risk during sterile product manufacture. Whilst most bacteria identified would present little threat to healthy individuals, others are opportunist pathogens that are hazardous for at risk patient groups who typically receive sterile pharmaceutical products.
01. Jimenez L. Microbial diversity in pharmaceutical product recalls and environments. PDA Journal of Pharmaceutical Science and Technology. 2007;61(5):383–99.
02. Sutton S and Jimenez L. A review of reported recalls involving microbiological control 2004-2011 with emphasis on FDA considerations of ‘objectable organisms’. American Pharmaceutical Review. 2012;15(1):42-57.
03. Champagne D. A white paper the microbial ID breakthrough: How DNA sequencing services help prevent catastrophic cleanroom shutdowns. [online]. Plymouth, UK: Microtest Ltd 2008. Available from: https://docplayer.net/15413484-The-microbial-id-breakthrough-how-dna-sequencing-services-help-prevent-catastrophic-cleanroom-shutdowns.html [Accessed 27 May 2022].
04. Gershman MD, Kennedy DJ, Noble‐Wang J, Kim C, Gullion J, Kacica M, et al. Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clinical Infectious Diseases. 2008;47(11):1372–9.
05. Shaban RZ, Maloney S, Gerrard J, Collignon P, Macbeth D, Cruickshank M, et al. Outbreak of health care-associated Burkholderia cenocepacia bacteremia and infection attributed to contaminated sterile gel used for central line insertion under ultrasound guidance and other procedures. American Journal of Infection Control. 2017;45(9):954–8.
06. Torjesen I. Parenteral nutrition product is suspected as cause of 18 cases of septicaemia in neonates. British Medical Journal. 2014;348(16):g3763–g3763.
07. Sprinks J. Baby deaths prompt investigation into contaminated drips at NHS hospitals. Nursing Children and Young People. 2014;26(6):7–7.
08. Teshome BF, Reveles KR, Lee GC, Ryan L and Frei CR. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. Journal of the American Pharmacists Association. 2014;54(4):441–5.
09. European Commission. Eudralex The rules governing medicinal products in the European Union volume 4 EU guidelines to good manufacturing practice medicinal products for human and veterinary use annex 1 manufacture of sterile medicinal products (corrected version). [online]. Brussels, Belgium: European Commission 2008. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf [Accessed 26 May 2022].
10. Whyte W and Eaton T. A cleanroom contamination control system. European Journal of Parenteral and Pharmaceutical Sciences, 2002;7(2):55-61.
11. Akers JE. Environmental monitoring and control: proposed standards, current practices, and future directions. PDA Journal of Pharmaceutical Science and Technology. 1997;51(1):36–47.
12. Sandle T. A review of cleanroom microflora: types, trends, and patterns. PDA Journal of Pharmaceutical Science and Technology. 2011;65(4):392–403.
13. Favero MS, Puleo JR, Marshall JH and Oxborrow GS. Comparison of microbial contamination levels among hospital operating rooms and industrial clean rooms. Applied Microbiology. 1968;16(3):480-486.
14. Favero MS, Puleo JR, Marshall JH and Oxborrow GS. Comparative levels and types of microbial contamination detected in industrial clean rooms. Applied Microbiology. 1966;14(4):539–51.
15. Park HK, Han JH, Joung Y, Cho SH, Kim SA and Kim SB. Bacterial diversity in the indoor air of pharmaceutical environment. Journal of Applied Microbiology. 2014;116(3):718–27.
16. Martín PG, González MB, Martínez AR, Lara VG and Naveros BC. Isolation and characterization of the environmental bacterial and fungi contamination in a pharmaceutical unit of mesenchymal stem cell for clinical use. Biologicals. 2012;40(5):330–7.
17. Tršan M, Seme K and Srčič S. The environmental monitoring in hospital pharmacy cleanroom and microbiota catalogue preparation. Saudi Pharmaceutical Journal. 2019;27(4):455–62.
18. Ljungqvist B and Reinmüller B. People as a contamination source in pharmaceutical clean rooms - source strengths and calculated concentrations of airborne contaminants. PDA Journal of Pharmaceutical Science and Technology. 2021;75(2):119–27.
19. Reinmüller B and Ljungqvist B. Modern cleanroom clothing systems: people as a contamination source. PDA Journal of Pharmaceutical Science and Technology. 2003;57(2):114–25.
20. Whyte W and Hejab M. Particle and microbial airborne dispersion from people. European Journal of Pharmaceutical Sciences. 2007;12(2):39–46.
21. Strauss L, Larkin J and Zhang KM. The use of occupancy as a surrogate for particle concentrations in recirculating, zoned cleanrooms. Energy and Buildings. 2011;43(11):3258–62.
22. Sandle T. People in cleanrooms: understanding and monitoring the personnel factor. Journal of GXP Compliance. 2014;18:1-5.
23. Ramstorp M, Gustavsson M and Gudmundsson A. Particle generation from humans – a method for experimental studies in cleanroom technology. In: Indoor Air, Proceedings of the 10th International Conference on Indoor Air Quality and Climate, Beijing, 4-9 Sept, 2005. Tsinghua University Press, China, 2005;1572-1576. International Society of Indoor Air Quality and Climate. https://www.isiaq.org/docs/PDFs/1572.pdf [Accessed June 14 2022].
24. Bryant R. Getting the best garment service [online]. HPCi Media, London, UK, 2010; https://cleanroomtechnology.com/news/article_page/Getting_the_best_garment_service/57844 [Accessed 14 June 2022].
25. Whyte W. Settling and impaction of particles into containers in manufacturing pharmacies. PDA Journal of Pharmaceutical Science and Technology 1981;35(5):255-61.
26. Romano F, Milani S and Joppolo CM. Airborne particle and microbiological human emission rate investigation for cleanroom clothing combinations. Building and Environment. 2020;180:106967.
27. Eaton T and Whyte W. Effective reusable cleanroom garments and evaluation of garment life. EJPPS European Journal of Parenteral and Pharmaceutical Sciences. 2020;25(4).
28. Kampf G. How long can nosocomial pathogens survive on textiles? A systematic review. GMS Hygiene Infection Control. 2020;15:Doc10.
29. Hsieh YL and Merry J. The adherence of Staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli on cotton, polyester and their blends. Journal of Applied Bacteriology. 1986;60(6):535–44.
30. Neely AN and Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. Journal of Clinical Microbiology. 2000;38(2):724–6.
31. Grangé J, Nguyen S, Bordenave J and Benoit G. Contamination of integral protective suits in the sterile environment used for producing total parenteral nutrition bags. Le Pharmacien Hospitalier. 2011;46(1):e12–8.
32. Smith LM, O’Driscoll NH and Lamb AJ. Gender influences bacterial contamination of reusable cleanroom operators’ garments following wear. European Journal of Parenteral and Pharmaceutical Sciences. 2021;25(2).
33. Licina D and Nazaroff WW. Clothing as a transport vector for airborne particles: chamber study. Indoor Air. 2018;28(3):404–14.
34. Whyte W and Eaton T. Microbial transfer by surface contact in cleanrooms. European Journal of Parenteral and Pharmaceutical Sciences. 2015;20(4):127–31.
35. Sattar SA, Springthorpe S, Mani S, Gallant M, Nair RC, Scott E, et al. Transfer of bacteria from fabrics to hands and other fabrics: development and application of a quantitative method using Staphylococcus aureus as a model. Journal of Applied Microbiology. 2001;90(6):962–70.
36. la Duc MT, Osman S, Vaishampayan P, Piceno Y, Andersen G, Spry JA, et al. Comprehensive census of bacteria in clean rooms by using DNA microarray and cloning methods. Applied Environmental Microbiology. 2009;75(20):6559–67.
37. la Duc MT, Dekas A, Osman S, Moissl C, Newcombe D, Venkateswaran K. Isolation and characterization of bacteria capable of tolerating the extreme conditions of clean room environments. Applied and Environmental Microbiology. 2007;73(8):2600–11.
38. Moissl C, Osman S, la Duc MT, Dekas A, Brodie E, DeSantis T, et al. Molecular bacterial community analysis of clean rooms where spacecraft are assembled. FEMS Microbiology Ecology. 2007;61(3):509–21.
39. Wu G fu and Liu XH. Characterization of predominant bacteria isolates from clean rooms in a pharmaceutical production unit. Journal of Zhejiang University Science B. 2007;8(9):666–72.
40. Hamdy AM, El-massry M, Kashef MT, Amin MA and Aziz RK. Toward the drug factory microbiome: microbial community variations in antibiotic-producing clean rooms. OMICS: A Journal of Integrative Biology. 2018;22(2):133–44.
41. Hyde W. Origins of bacteria in the cleanroom and their growth requirements. PDA Journal of Pharmaceutical Science and Technology. 1998;52(4):154–8.
42. Sheraba NS, Yassin AS and Amin MA. High-throughput molecular identification of Staphylococcus spp. isolated from a clean room facility in an environmental monitoring program. BMC Research Notes. 2010;3:278.
43. Janda JM and Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. Journal of Clinical Microbiology. 2007;45(9):2761–4.
44. Petti CA, Polage CR and Schrecberger P. The role of 16S rRNA gene sequencing in identification of microorganisms misidentified by conventional methods. Journal of Clinical Microbiology. 2005;43(12):6123-5.
45. Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP and Raoult D. 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. Journal of Clinical Microbiology. 2000;38(10):3623-30.
46. Mignard S and Flandrois JP. 16S rRNA sequencing in routine bacterial identification: A 30-month experiment. Journal of Microbiological Methods. 2006;67(3):574–81.
47. Schloss PD and Handelsman J. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Applied and Environmental Microbiology. 2005;71(3):1501–6.
48. Collins MD, Brown J and Jones D. Brachybacterium faecium gen. nov., sp. nov., a coryneform bacterium from poultry deep litter. International Journal of Systematic Bacteriology. 1988;38(1):45–8.
49. Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Review of Dermatology. 2010;5(2):183–95.
50. Saxena AK, Kumar M, Chakdar H, Anuroopa N and Bagyaraj DJ. Bacillus species in soil as a natural resource for plant health and nutrition. Journal of Applied Microbiology. 2020;128(6):1583–94.
51. Kloos WE and Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Applied Microbiology. 1975;30(3):381–95.
52. Funke G, Haase G, Schnitzler N, Schrage N and Reinert RR. Endophthalmitis due to microbacterium species: case report and review of microbacterium infections. Clinical Infectious Diseases. 1997;24(4):713–6.
53. Tamai K, Akashi Y, Yoshimoto Y, Yaguchi Y, Takeuchi Y, Shiigai M, et al. First case of a bloodstream infection caused by the genus Brachybacterium. Journal of Infection and Chemotherapy. 2018;24(12):998–1003.
54. Szczerba I. Occurrence and number of bacteria from the Micrococcus,Kocuria, Nesterenkonia, Kytococcus and Dermacoccus genera on skin and mucous membranes in humans. Medycyna Doswiadczalna i Mikrobiologia. 2003;55(1):67–74.
55. Tsai CY, Su S hsin, Cheng YH, Chou Y lin, Tsai TH and Lieu AS. Kocuria varians infection associated with brain abscess: A case report. BMC Infectious Diseases. 2010;10(1):102.
56. Grady EN, MacDonald J, Liu L, Richman A and Yuan ZC. Current knowledge and perspectives of Paenibacillus: a review. Microbial Cell Factories. 2016;15(1):203.
57. Rodrigues DF, da C Jesus E, Ayala-del-Río HL, Pellizari VH, Gilichinsky D, Sepulveda-Torres L, et al. Biogeography of two cold-adapted genera: Psychrobacter and Exiguobacterium. The ISME Journal. 2009;3(6):658–65.
58. Grice EA and Segre JA. The skin microbiome. Nature Reviews Microbiology. 2011;9(4):244–53.
59. Turnbull PCB. Medical Microbiology. 4th Edition. Baron S, editor. Galveston (TX): University of Texas Medical Branch at Galveston; 1996.
60. Moissl-Eichinger C, Auerbach AK, Probst AJ, Mahnert A, Tom L, Piceno Y, et al. Quo vadis? microbial profiling revealed strong effects of cleanroom maintenance and routes of contamination in indoor environments. Scientific Reports. 2015;5(1):9156.
61. Smith LM, O’ Driscoll NH and Lamb AJ. A comparison of the bacterial contamination of the surface of cleanroom operators’ garments following donning with and without gloves. EJPPS European Journal of Parenteral and Pharmaceutical Sciences. 2021;26(3).
62. Baiget Francesch M. From commensalism to parasitism: the dangers of underestimating cleanroom bacterial contaminants. [online]. Russell Publishing Ltd, Kent, UK, 2020; https://www.europeanpharmaceuticalreview.com/article/117688/from-commensalism-to-parasitism-the-dangers-of-underestimating-cleanroom-bacterial-contaminants/ [Accessed 14 June 2022].
63. Dhyani A, Gupta V, Chauhan A, Seshendra Kumar RN and Chakravarty S. Meningitis caused by Micrococcus luteus: case report and review of literature. IP International Journal of Medical Microbiology and Tropical Diseases. 2019;5(1):63–4.
64. Albertson D. Septic shock with Micrococcus luteus. Archives of Internal Medicine. 1978;138(3):487.
65. Ianniello NM, Andrade DC, Ivancic S, Eckardt PA and Lemos Ramirez JC. Native valve infective endocarditis due to Micrococcus luteus in a non-hodgkin’s lymphoma patient. IDCases. 2019;18:e00657.
66. Erbasan F. Brain abscess caused by Micrococcus luteus in a patient with systemic lupus erythematosus: case-based review. Rheumatology International. 2018;38(12):2323–8.
67. Jeong DW, Heo S, Ryu S, Blom J and Lee JH. Genomic insights into the virulence and salt tolerance of Staphylococcus equorum. Scientific Reports. 2017;7(1):5383.
68. Resch M, Nagel V, Hertel C. Antibiotic resistance of coagulase-negative staphylococci associated with food and used in starter cultures. International Journal of Food Microbiology. 2008;127(1–2):99–104.
69. Spencer RC. Bacillus anthracis. Journal of Clinical Pathology. 2003;56:182–7.
70. Hugh-Jones M and Blackburn J. The ecology of Bacillus anthracis. Molecular aspects of medicine. 2009;30(6):356–67.
71. Branquinho R, Sousa C, Lopes J, Pintado ME, Peixe LV and Osório H. Differentiation of Bacillus pumilus and Bacillus safensis Using MALDI-TOF-MS. PLoS ONE. 2014;9(10):e110127.
72. Lateef A, Adelere IA and Gueguim-Kana EB. The biology and potential biotechnological applications of Bacillus safensis. Biologia (Bratisl). 2015;70(4):411–9.
73. From C, Hormazabal V, Granum PE. Food poisoning associated with pumilacidin-producing Bacillus pumilus in rice. International Journal of Food Microbiology. 2007;115(3):319–24.
74. Haymore BR, Akers KS and Ferguson TM. A case of persistent Bacillus pumilis bacteremia associated with cholangitis. Journal of Infection. 2006;52(2):154–5.
75. Bentur H, Dalzell A and Riordan F. Central venous catheter infection with Bacillus pumilus in an immunocompetent child: a case report. Annals of Clinical Microbiology and Antimicrobials. 2007;6(1):12.
76. Tena D, Martinez-Torres J a., Perez-Pomata MT, Saez-Nieto JA, Rubio V and Bisquert J. Cutaneous infection due to Bacillus pumilus: report of 3 cases. Clinical Infectious Diseases. 2007;44(4):e40–2.
77. Johnson BT, Shaw LN, Nelson DC and Mayo JA. Extracellular proteolytic activities expressed by Bacillus pumilus isolated from endodontic and periodontal lesions. Journal of Medical Microbiology. 2008;57(5):643–51.
78. Sacchi CT, Whitney AM, Mayer LW, Morey R, Steigerwalt A, Boras A, et al. Sequencing of 16S rRNA gene: A rapid tool for identification of Bacillus anthracis. Emerging Infectious Diseases. 2002;8(10):1117–23.
79. Stakebrandt E and Ebers J. Taxonomic parameters revisited: tarnished gold standards. Microbiology Today. 2006;8(4):6-9.
80. Janda JM and Abbott SL. Bacterial identification for publication: when is enough enough? Journal of Clinical Microbiology. 2002;40(6):1887–91.
81. Ying S, Zeng DN, Chi L, Tan Y, Galzote C, Cardona C, et al. The influence of age and gender on skin-associated microbial communities in urban and rural human populations. PLOS ONE. 2015;10(10):e0141842.
82. Fierer N, Hamady M, Lauber CL and Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(46):17994–9.
83. Chen TH, Chen WP and Wang MJJ. The effect of air permeability and water vapor permeability of cleanroom clothing on physiological responses and wear comfort. Journal of Occupational and Environmental Hygiene. 2014;11(6):366–76.
84. Chen TH, Lin CL and Wang MJJ. The evaluation of double-layer clothing in a semiconductor manufacturing environment. Human Factors and Ergonomics in Manufacturing and Service Industries. 2014;24(2):207–15.
85. Takeuchi M, Fang CX and Yokota A. Taxonomic study of the genus Brachybacterium: proposal of Brachybacterium conglomeratum sp. nov., nom. rev., Brachybacterium paraconglomeratum sp. nov., and Brachybacterium rhamnosum sp. nov. International Journal of Systematic Bacteriology. 1995;45(1):160–8.
86. Diriba T, Marta M, Euan KJ, Pietro PMI and Fassil A. The functional characterisation of soybean (Glycine max L.) rhizospheric bacteria indigenous to Ethiopian soils. African Journal of Agricultural Research. 2019;14(33):1659–73.
87. Gneiding K, Frodl R and Funke G. Identities of Microbacterium spp. encountered in human clinical specimens. Journal of Clinical Microbiology. 2008;46(11):3646–52. Author Information
Dr Laurie M. Smith
Lecturer in Pharmaceutical Sciences
School of Pharmacy and Life Sciences,
Sir Ian Wood Building,
Robert Gordon University,
Dr Christina Lowes
Corporate Health and Safety Advisor
Royal Veterinary College,
University of London,
4 Royal College Street,
Dr Noëlle H. O’ Driscoll
Lecturer in Pharmaceutical Microbiology
School of Pharmacy and Life Sciences,
Sir Ian Wood Building,
Robert Gordon University,
Prof Andrew J. Lamb
Dean of Graduate School
Ishbel Gordon Building,
Robert Gordon University,
This research project did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. However, the study was funded by the Research Committee from the School of Pharmacy and Life Sciences for which thanks are offered.
Conflict of Interest Declaration
The authors declare that they have no competing interests.
A research ethics self-assessment (RESA) form was submitted in respect to the Robert Gordon University’s Research Ethics Policy. This application was reviewed and approved by the Ethical Review Panel of the School of Pharmacy and Life Sciences.
The authors would like to thank the MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences at the University of Dundee for their sequencing services.